Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Fraser-Pitt
D. Fraser-Pitt
Cysteamine
Cystic fibrosis
Medicine
Pathology
Virulence
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
524: Transcriptomic analysis on the effects of cysteamine in synthetic sputum on the virulence and metabolism of Pseudomonas aeruginosa and Burkholderia cenocepacia
2021
Journal of Cystic Fibrosis
S. Dolan
D. Fraser-Pitt
D. O'Neil
Show All
Source
Cite
Save
Citations (0)
431: Antivirulence activities of cysteamine and protection from Pseudomonas toxicity in the Galleria mellonella model
2021
Journal of Cystic Fibrosis
D. Fraser-Pitt
S. Dolan
David Smith
D ONeil
Show All
Source
Cite
Save
Citations (0)
WS12-6 Evaluating appropriate PROMs in CARE-CF-1 trial: Lynovex® (cysteamine) an oral adjunct to SOC interventions in cystic fibrosis infectious exacebations
2019
Journal of Cystic Fibrosis
Graham Devereux
Stephen J. Bourke
C. Daines
S. Doe
R. Dougherty
R. Franco
A. Innes
B. Kopp
J. Lascano
D. Layish
G. McGregor
L. Murray
D. Peckham
T Smith
V Lucidi
S. Volpi
Emma Lovie
Jennifer Robertson
D. Fraser-Pitt
Deborah O'neil
Show All
Source
Cite
Save
Citations (0)
P114 Cysteamine impairs lipoic acid cofactor-mediated aspects of bacterial metabolism in cystic fibrosis pathogens
2019
Journal of Cystic Fibrosis
D. Fraser-Pitt
D. Smith
P. Perenyi
Deborah O'neil
Show All
Source
Cite
Save
Citations (0)
P111 Cysteamine has wide-ranging anti-virulence properties against cystic fibrosis pathogens
2019
Journal of Cystic Fibrosis
D. Fraser-Pitt
D. Smith
Deborah O'neil
Show All
Source
Cite
Save
Citations (0)
1